Course info
The self-paced course features 7 learning units addressing prophylactic and cancer vaccines from the scientific and regulatory point of view. The course is designed for professionals working on vaccine development who need an introduction to the (EU) regulatory requirements associated with the field. The course covers mainly prophylactic vaccines including CMC, preclinical and Phase I-II of vaccine development, and touches on therapeutic and cancer vaccines as well, both from the scientific and regulatory point of view. The course is based on materials developed as part of the TRANSVAC project that was supported by Horizon 2020